Onyeama Sara-Jane N, Hanson Sheila J, Dasgupta Mahua, Hoffmann Raymond G, Faustino Edward Vincent S
1Medical College of Wisconsin, Milwaukee, WI. 2Department of Pediatrics, Medical College of Wisconsin, WI. 3Critical Care Division, Children's Hospital of Wisconsin, Milwaukee, WI. 4Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI. 5Department of Pediatrics, Yale School of Medicine, New Haven, CT.
Pediatr Crit Care Med. 2016 Aug;17(8):e352-61. doi: 10.1097/PCC.0000000000000854.
To identify patient, hospital, and central venous catheter factors that may influence the use of low-dose heparin infusion for central venous catheter patency in critically ill children.
Secondary analysis of an international multicenter observational study.
Fifty-nine PICUs over four study dates in 2012, involving seven countries.
Children less than 18 years old with a central venous catheter who were admitted to a participating unit and enrolled in the completed Prophylaxis against Thrombosis Practice study were included. All overflow patients were excluded.
None.
Of the 2,484 patients in the Prophylaxis against Thrombosis Practice study, 1,312 patients had a central venous catheter. Five hundred seven of those patients used low-dose heparin infusion. The frequency of low-dose heparin infusion was compared across various patient, hospital, and central venous catheter factors using chi-square, Mann-Whitney U, and Fisher exact tests. In the multivariate analysis, age was not a significant factor for low-dose heparin infusion use. Patients with pulmonary hypertension had decreased low-dose heparin infusion use, whereas those with active surgical or trauma diagnoses had increased low-dose heparin infusion use. All centrally inserted central venous catheters were more likely to use low-dose heparin infusion when compared with peripherally inserted central venous catheters. The Asia-Pacific region showed increased low-dose heparin infusion use, along with community hospitals and smaller ICUs (< 10 beds).
Patient, central venous catheter, and hospital factors are associated with the use of low-dose heparin infusion in critically ill children. Further study is needed to evaluate the efficacy and persistence of low-dose heparin infusion use.
确定可能影响在危重症儿童中使用低剂量肝素输注以保持中心静脉导管通畅的患者、医院及中心静脉导管相关因素。
一项国际多中心观察性研究的二次分析。
2012年四个研究日期间的59个儿科重症监护病房,涉及7个国家。
纳入入住参与研究单位且参加已完成的预防血栓形成实践研究的18岁以下中心静脉置管儿童。排除所有溢出患者。
无。
在预防血栓形成实践研究的2484例患者中,1312例患者有中心静脉导管。其中507例患者使用低剂量肝素输注。使用卡方检验、曼-惠特尼U检验和费舍尔精确检验,比较了不同患者、医院及中心静脉导管因素下低剂量肝素输注的频率。在多变量分析中,年龄不是低剂量肝素输注使用的显著因素。患有肺动脉高压的患者低剂量肝素输注使用率降低,而有外科手术或创伤诊断的患者低剂量肝素输注使用率增加。与外周置入中心静脉导管相比,所有中心置入的中心静脉导管更有可能使用低剂量肝素输注。亚太地区、社区医院和较小的重症监护病房(<10张床位)低剂量肝素输注使用率增加。
患者、中心静脉导管及医院因素与危重症儿童低剂量肝素输注的使用相关。需要进一步研究以评估低剂量肝素输注使用的疗效和持续性。